粒子線治療の世界市場予測（～2023年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 23
2.1.2.2 Breakdown of primaries 24
2.2 MARKET SIZE ESTIMATION 24
2.2.1 PRODUCT-BASED MARKET ESTIMATION 24
2.2.2 VOLUME-BASED MARKET ESTIMATION 26
2.2.3 PRIMARY RESEARCH VALIDATION 28
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 RESEARCH LIMITATIONS AND ASSUMPTIONS 30
2.4.1 LIMITATIONS 30
2.4.2 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 PARTICLE THERAPY: MARKET OVERVIEW 36
4.2 REGIONAL ANALYSIS: PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE 37
4.3 PARTICLE THERAPY MARKET SIZE, BY TYPE 37
4.4 PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE 38
4.5 REGIONAL ANALYSIS: PARTICLE THERAPY MARKET, BY APPLICATION 39
4.6 PARTICLE THERAPY MARKET, BY REGION 40
 
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Advantages offered by particle therapy over photon therapy 42
5.2.1.2 Growing global prevalence of cancer 42
5.2.1.3 Growing adoption of particle therapy in clinical trials 43
5.2.1.4 Increasing number of particle therapy centers worldwide 44
5.2.2 RESTRAINTS 44
5.2.2.1 Infrastructural challenges in healthcare facilities 44
5.2.2.2 Affordability and accessibility of treatments 45
5.2.2.3 Unfavorable reimbursement policies and limited insurance coverage for particle therapy 45
5.2.3 OPPORTUNITIES 46
5.2.3.1 Emerging markets 46
5.2.4 INDUSTRY TRENDS 47
5.2.4.1 GROWING ADOPTION OF PENCIL-BEAM SCANNING 47
6 PARTICLE THERAPY MARKET, BY TYPE 48
6.1 INTRODUCTION 49
6.2 PROTON THERAPY 50
6.2.1 PROTON THERAPY IS INCREASINGLY BEING ADOPTED AS A PRIMARY TREATMENT MODE FOR VARIOUS CANCER TYPES 50
6.3 HEAVY ION THERAPY 51
6.3.1 THE USE OF HEAVY ION THERAPY IS STILL IN THE EXPERIMENTAL PHASE ACROSS MANY REGIONS 51
7 PARTICLE THERAPY MARKET, BY PRODUCT & SERVICE 52
7.1 INTRODUCTION 53
7.2 PRODUCTS 54
7.2.1 CYCLOTRONS 56
7.2.1.1 Leading players in the particle therapy market mainly manufacture cyclotrons 56
7.2.2 SYNCHROTRONS 57
7.2.2.1 Increasing investments into the development of synchrotron facilities are contributing to market growth 57
7.2.3 SYNCHROCYCLOTRONS 58
7.2.3.1 The high space requirements of synchrocyclotrons are limiting their widespread adoption 58
7.3 SERVICES 59
 
8 PARTICLE THERAPY MARKET, BY SYSTEM 60
8.1 INTRODUCTION 61
8.2 MULTI-ROOM SYSTEMS 62
8.2.1 LOWER SHIELDING REQUIREMENTS AND FASTER BEAM-SWITCHING CAPABILITIES OF MULTI-ROOM SYSTEMS ARE INCREASING INTEREST AMONG END USERS 62
8.3 SINGLE-ROOM SYSTEMS 63
8.3.1 COMPACT STRUCTURE AND REDUCED CAPITAL COSTS ARE LEADING TO HIGH GROWTH OF SINGLE-ROOM SYSTEMS 63
9 PARTICLE THERAPY MARKET, BY CANCER TYPE 64
9.1 INTRODUCTION 65
9.1.1 PEDIATRIC CANCER 66
9.1.1.1 BETTER CONTROL OF RADIATION WITH PARTICLE THERAPY MAKES IT THE MOST SUITABLE TREATMENT MODE FOR PEDIATRIC CANCER 66
9.1.2 PROSTATE CANCER 66
9.1.2.1 PARTICLE THERAPY OFFERS A MINIMALLY INVASIVE ALTERNATIVE WITH INCREASED ACCURACY FOR PROSTATE CANCER TREATMENT 66
9.1.3 LUNG CANCER 67
9.1.3.1 RISING NUMBER OF CLINICAL TRIALS TO OPTIMIZE THE USE OF PARTICLE THERAPY FOR LUNG CANCER IS DRIVING THE GROWTH OF THE MARKET 67
9.1.4 BREAST CANCER 67
9.1.4.1 LIMITED RADIATION EXPOSURE WITH REDUCED SIDE-EFFECTS IS INCREASING THE ADOPTION OF PARTICLE THERAPY FOR BREAST CANCER 67
9.1.5 HEAD AND NECK CANCER 67
9.1.5.1 THE USE OF PENCIL-BEAM SCANNING FOR PROTON THERAPY SUPPORTS MARKET GROWTH FOR THIS SEGMENT 67
9.1.6 OTHER CANCERS 68
10 PARTICLE THERAPY MARKET, BY APPLICATION 69
10.1 INTRODUCTION 70
10.2 TREATMENT APPLICATIONS 71
10.2.1 INTRODUCTION OF SMALL FOOTPRINT SINGLE-ROOM PARTICLE THERAPY CENTRES IS PROMOTING THE ADOPTION OF PARTICLE THERAPY FOR CANCER TREATMENT 71
10.3 RESEARCH APPLICATIONS 72
10.3.1 INCREASING AVAILABILITY OF FUNDING FOR PARTICLE THERAPY-RELATED RESEARCH PROJECTS IS PROVIDING GROWTH OPPORTUNITIES IN RESEARCH APPLICATIONS 72
 
11 PARTICLE THERAPY MARKET, BY REGION 74
11.1 INTRODUCTION 75
11.2 NORTH AMERICA 77
11.2.1 US 80
11.2.1.1 Growing number of particle therapy centers in the US to drive market growth 80
11.2.2 CANADA 82
11.2.2.1 Canadian government undertaking initiatives to include particle therapy as a treatment method 82
11.3 EUROPE 83
11.3.1 FRANCE 87
11.3.1.1 Increasing healthcare expenditure in France is supporting the adoption of particle therapy products 87
11.3.2 GERMANY 88
11.3.2.1 Increasing research in the field of proton & heavy ion therapy to drive the growth of the particle therapy market in Germany 88
11.3.3 UK 90
11.3.3.1 Cyclotrons segment dominated the particle therapy market in the UK 90
11.3.4 REST OF EUROPE 91
11.4 ASIA PACIFIC 93
11.4.1 JAPAN 97
11.4.1.1 Japan is the largest user of heavy ion therapy for the treatment of various types of cancers 97
11.4.2 CHINA 99
11.4.2.1 Growing interest of major market players to increase their presence in China will drive the growth of the particle therapy market in the country 99
11.4.3 INDIA 101
11.4.3.1 Leading product manufacturers are entering the Indian particle therapy market owing to the high growth opportunities in the country 101
11.4.4 REST OF ASIA PACIFIC 102
11.5 REST OF THE WORLD 104
11.5.1 INADEQUATE HEALTHCARE INFRASTRUCTURE IS RESTRAINING THE WIDESPREAD ADOPTION OF PARTICLE THERAPY IN THE REGION 104
12 COMPETITIVE LANDSCAPE 108
12.1 INTRODUCTION 108
12.2 MARKET SHARE ANALYSIS 109
12.3 COMPETITIVE SCENARIO 110
12.3.1 PRODUCT LAUNCHES AND APPROVALS 110
12.3.2 ACQUISITIONS 110
12.3.3 EXPANSIONS 111
12.3.4 AGREEMENTS AND COLLABORATIONS 111
 
13 COMPANY PROFILES: PARTICLE THERAPY MARKET 112
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 VARIAN MEDICAL SYSTEMS, INC. 112
13.2 ION BEAM APPLICATIONS SA (IBA) 115
13.3 MEVION MEDICAL SYSTEMS, INC. 118
13.4 PROVISION HEALTHCARE, LLC 120
13.5 SUMITOMO HEAVY INDUSTRIES, LTD. 122
13.6 HITACHI, LTD. 124
13.7 OPTIVUS PROTON THERAPY, INC. 126
13.8 PROTOM INTERNATIONAL, INC. 127
13.9 ADVANCED ONCOTHERAPY PLC. 128
13.10 DANFYSIK A/S 130
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 131
14.1 DISCUSSION GUIDE 131
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 135
14.3 AVAILABLE CUSTOMIZATIONS 137
14.4 RELATED REPORTS 137
14.5 AUTHOR DETAILS 138